Analysts who follow Neuroone Medical Technologies Corp (NMTC) on average expect it to rise 93.01% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns NMTC an Analyst Ranking of 34, which means it ranks higher than 34 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating NMTC a Buy today. Find out what this means to you and get the rest of the rankings on NMTC!